Research Analysts Set Expectations for Celanese Q4 Earnings

Celanese Co. (NYSE:CE - Free Report) - Investment analysts at Zacks Research reduced their Q4 2025 EPS estimates for shares of Celanese in a research report issued to clients and investors on Monday, May 26th. Zacks Research analyst R. Department now anticipates that the basic materials company will post earnings of $1.25 per share for the quarter, down from their prior forecast of $1.54. The consensus estimate for Celanese's current full-year earnings is $8.79 per share. Zacks Research also issued estimates for Celanese's Q2 2026 earnings at $1.44 EPS, Q3 2026 earnings at $2.21 EPS, FY2026 earnings at $6.22 EPS, Q1 2027 earnings at $1.98 EPS and FY2027 earnings at $7.92 EPS.

CE has been the topic of a number of other reports. KeyCorp raised their target price on Celanese from $71.00 to $76.00 and gave the company an "overweight" rating in a research report on Wednesday, May 7th. Deutsche Bank Aktiengesellschaft lifted their price target on Celanese from $70.00 to $75.00 and gave the stock a "buy" rating in a research note on Thursday, March 27th. Wall Street Zen raised Celanese from a "sell" rating to a "hold" rating in a research note on Wednesday, May 14th. Mizuho set a $45.00 target price on shares of Celanese in a research note on Tuesday, April 15th. Finally, Citigroup cut their price target on Celanese from $58.00 to $52.00 and set a "neutral" rating for the company in a report on Friday, April 4th. One research analyst has rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Hold" and an average price target of $61.94.

Celanese Stock Performance

CE traded down $0.93 during midday trading on Thursday, hitting $51.90. 519,196 shares of the company were exchanged, compared to its average volume of 2,212,417. The firm has a market capitalization of $5.68 billion, a price-to-earnings ratio of -3.73, a price-to-earnings-growth ratio of 1.05 and a beta of 1.09. Celanese has a 1-year low of $36.29 and a 1-year high of $152.50. The company's 50 day simple moving average is $47.69 and its 200 day simple moving average is $59.53. The company has a current ratio of 1.34, a quick ratio of 0.76 and a debt-to-equity ratio of 1.98.

Celanese (NYSE:CE - Get Free Report) last announced its quarterly earnings data on Monday, May 5th. The basic materials company reported $0.57 earnings per share for the quarter, beating analysts' consensus estimates of $0.37 by $0.20. The business had revenue of $2.39 billion for the quarter, compared to analyst estimates of $2.26 billion. Celanese had a positive return on equity of 12.86% and a negative net margin of 14.81%. The company's revenue was down 8.5% on a year-over-year basis. During the same period in the prior year, the company earned $2.08 earnings per share.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the business. Sanctuary Advisors LLC boosted its holdings in Celanese by 5.1% in the fourth quarter. Sanctuary Advisors LLC now owns 7,213 shares of the basic materials company's stock valued at $521,000 after purchasing an additional 351 shares in the last quarter. Twelve Points Wealth Management LLC boosted its holdings in shares of Celanese by 157.8% in the 4th quarter. Twelve Points Wealth Management LLC now owns 10,124 shares of the basic materials company's stock valued at $701,000 after buying an additional 6,197 shares in the last quarter. New England Research & Management Inc. purchased a new position in shares of Celanese in the 4th quarter valued at $768,000. Sei Investments Co. grew its position in shares of Celanese by 91.8% in the 4th quarter. Sei Investments Co. now owns 126,660 shares of the basic materials company's stock valued at $8,766,000 after buying an additional 60,621 shares during the last quarter. Finally, Barclays PLC raised its stake in Celanese by 14.0% during the 3rd quarter. Barclays PLC now owns 281,709 shares of the basic materials company's stock worth $38,300,000 after acquiring an additional 34,658 shares in the last quarter. Hedge funds and other institutional investors own 98.87% of the company's stock.

Insider Transactions at Celanese

In other Celanese news, SVP Mark Christopher Murray bought 1,479 shares of the company's stock in a transaction that occurred on Friday, May 23rd. The shares were purchased at an average price of $52.18 per share, with a total value of $77,174.22. Following the completion of the acquisition, the senior vice president now directly owns 15,468 shares of the company's stock, valued at $807,120.24. This represents a 10.57% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.33% of the company's stock.

Celanese Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, May 12th. Stockholders of record on Monday, April 28th were given a dividend of $0.03 per share. The ex-dividend date of this dividend was Monday, April 28th. This represents a $0.12 annualized dividend and a dividend yield of 0.23%. Celanese's dividend payout ratio is presently -0.79%.

About Celanese

Celanese Corporation, a chemical and specialty materials company, manufactures and sells high performance engineered polymers in the United States and internationally. It operates through Engineered Materials and Acetyl Chain. The Engineered Materials segment develops, produces, and supplies specialty polymers for automotive and medical applications, as well as for use in industrial products and consumer electronics.